Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
AI-driven billing for more medically complex inpatient stays has resulted in nearly $1 billion in additional healthcare costs over the last two years, according to new analysis by the Blue Cross Blue Shield Association.
More than 60% of hospitals and…
An artificial intelligence (AI) algorithm increased aneurysm detection, identifying 55 true-positive brain aneurysms that radiologists had missed, representing a 39% relative increase in detection.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us